| abstract |
The invention relates to the application of quercetin-3-O-locust glucoside as an inhibitor of calcium ion channels, and belongs to the field of medicine. The invention also provides quercetin-3-O-locust glucoside in the preparation and treatment of cardiovascular disease and coronary heart disease. , atherosclerosis, end-stage renal failure, neurological disease, chronic pain, acute pain or inflammatory disease drug use, demonstrated its ability to inhibit calcium ion channels, especially TRPC ion channels, expanded quercetin-3- Use of O-Sophoroside. |